Departments of Neurology and Psychiatry, New York University School of Medicine, New York, NY.
Division of Hypertension and Renal Disease, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Clin Kidney J. 2012 Feb;5(1):13-6. doi: 10.1093/ndtplus/sfr156. Epub 2012 Jan 28.
Bone disease remains a major cause of morbidity after renal transplantation. Post-transplant osseous complications include osteoporosis and osteonecrosis, both historically associated with glucocorticoids, and a newer syndrome of bone pain associated with calcineurin inhibitors. Calcineurin inhibitor-induced pain syndrome (CIPS) is a reversible etiology of lower extremity bone pain and bone marrow edema reported in patients receiving cyclosporine or tacrolimus after solid organ or bone marrow transplantation. While the syndrome's pathophysiology is unclear, bone insufficiency and epiphyseal impaction may play a role. We review the literature on this increasingly important post-transplant entity and describe a case illustrating the syndrome's key features.
骨骼疾病仍然是肾移植后发病率的主要原因。移植后的骨骼并发症包括骨质疏松症和骨坏死,这两种疾病都与糖皮质激素有关,还有一种新的与钙调神经磷酸酶抑制剂相关的骨骼疼痛综合征。钙调神经磷酸酶抑制剂诱导的疼痛综合征(CIPS)是一种接受环孢素或他克莫司治疗的实体器官或骨髓移植患者出现下肢骨骼疼痛和骨髓水肿的可逆病因。虽然该综合征的病理生理学尚不清楚,但骨骼功能不全和骺板嵌压可能起作用。我们回顾了有关这种日益重要的移植后实体的文献,并描述了一个病例,说明了该综合征的主要特征。